| Residential College | false |
| Status | 已發表Published |
| A novel acquired EGFR-SEPT14 fusion confers differential drug resistance to EGFR inhibitors in lung adenocarcinoma | |
Weidong Wang1,5,6,7; Wang Lv1; Hui Wang1; Yang Xu3; Junrong Yan3; Han-Ming Shen4,5 ; Liqun Shan1,2 ; Jian Hu1
| |
| 2023-04-24 | |
| Media | Genes & Diseases |
| DOI | 10.1016/j.gendis.2023.02.019 |
| Language | 英語English |
| URL | View the original |
| Scopus ID | 2-s2.0-85162199986 |
| Fulltext Access | |
| Citation statistics | |
| Document Type | Other |
| Collection | Faculty of Health Sciences |
| Corresponding Author | Liqun Shan; Jian Hu |
| Affiliation | 1.Department of Thoracic Surgery,The First Affiliated Hospital,School of Medicine,Zhejiang University,Hangzhou,Zhejiang,310003,China 2.Department of Thoracic Surgery,The First People's Hospital of Wenling,Wenling,Zhejiang,317599,China 3.Medical Department,Nanjing Geneseeq Technology Inc.,Nanjing,210000,China 4.Department of Physiology,Yong Loo Lin School of Medicine,National University of Singapore,Singapore,119077,Singapore 5.Faculty of Health Sciences,University of Macau,Macau,519000,China 6.Department of Thoracic Surgery,Sun Yat-sen University Cancer Center,Guangzhou,Guangdong,510060,China 7.Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China,Collaborative Innovation Center for Cancer Medicine,Guangzhou,Guangdong,510060,China |
| First Author Affilication | Faculty of Health Sciences |
| Recommended Citation GB/T 7714 | Weidong Wang,Wang Lv,Hui Wang,et al. A novel acquired EGFR-SEPT14 fusion confers differential drug resistance to EGFR inhibitors in lung adenocarcinoma. 2023-04-24. |
| Files in This Item: | There are no files associated with this item. | |||||
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment